Momenta Pharmaceuticals
MNTA
#2754
Rank
โ‚ฌ5.34 B
Marketcap
44,97ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Momenta Pharmaceuticals (MNTA)

Revenue in 2020 (TTM): โ‚ฌ27.11 Million

According to Momenta Pharmaceuticals's latest financial reports the company's current revenue is โ‚ฌ25.76 Million. In 2019 the company made a revenue of โ‚ฌ20.45 Million a decrease over the revenue in the year 2018 that were of โ‚ฌ64.77 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Momenta Pharmaceuticals from 2004 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)โ‚ฌ27.11 M32.56%
2019โ‚ฌ20.45 M-68.42%
2018โ‚ฌ64.77 M-45.57%
2017โ‚ฌ0.11 B26.7%
2016โ‚ฌ93.93 M22.28%
2015โ‚ฌ76.82 M71.58%
2014โ‚ฌ44.77 M47.33%
2013โ‚ฌ30.38 M-44.52%
2012โ‚ฌ54.77 M-77.42%
2011โ‚ฌ0.24 B142.41%
2010โ‚ฌ0.10 B476.68%
2009โ‚ฌ17.35 M38.97%
2008โ‚ฌ12.48 M-32.42%
2007โ‚ฌ18.47 M31.7%
2006โ‚ฌ14.02 M13.06%
2005โ‚ฌ12.4 M84.86%
2004โ‚ฌ6.71 M